Urologix, ProstaLund and ACMI Settle Patent Suit
Urologix originally brought the lawsuit in March 2002 in U.S. District Court in the Eastern District of Wisconsin.
Under the terms of the settlement, the parties will dismiss all pending legal claims against each other and Urologix will grant ProstaLund a non-exclusive, royalty-free license under U.S. Patent Nos. 5,230,004 ('004), 5,509,929 and 5,480,417 to sell the ProstaLund transurethral...
To view the full article, register now.